Recruiting

Elix Supplements for Uterine Fibroid Symptoms

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Elix Daily Harmony

Dietary Supplement
Who is being recruted

Dysmenorrhea+10

+ Leiomyoma

+ Menstruation Disturbances

From 20 to 45 Years
+41 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: August 2025
See protocol details

Summary

Principal SponsorZenchi, Inc.
Study ContactPatrick Renner, MSc
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 2025

Actual date on which the first participant was enrolled.

This study is focused on understanding how two herbal supplements, Elix Cycle Balance and Elix Daily Harmony, affect symptoms related to uterine fibroids and overall quality of life. It involves 42 participants who experience these fibroid-related symptoms. The study is important because uterine fibroids can cause discomfort and impact daily living, and current treatments may not be effective for everyone. By exploring the effects of these herbal supplements, researchers hope to find new ways to manage symptoms and improve the quality of life for those affected by fibroids. Participants in the study will take the herbal supplements on their own each day over a period of 24 weeks. Throughout the study, they will fill out specific questionnaires at set times to track any changes in the severity of their symptoms and their general well-being. The study is conducted virtually, meaning participants can complete it from their own homes, making it more convenient. The results of the questionnaires will help researchers evaluate the effectiveness of the supplements in reducing symptoms and improving life quality.

Official TitleAn Open-Label, Single-Group Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
NCT07078682
Principal SponsorZenchi, Inc.
Study ContactPatrick Renner, MSc
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

42 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 20 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

DysmenorrheaLeiomyomaMenstruation DisturbancesNeoplasmsNeoplasms by Histologic TypeNeoplasms, Muscle TissueNeurologic ManifestationsPainPathologic ProcessesSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic PainNeoplasms, Connective and Soft Tissue

Criteria

16 inclusion criteria required to participate
Be female.
Be aged 20-45.
BMI 18.5 - 24.9 kg/m2
Self-reported prior diagnosis of uterine fibroids.
Show More Criteria
25 exclusion criteria prevent from participating
Does not experience a regular menstrual cycle (21-35 days).
Does not experience menstrual cramping.
Follows an extreme diet intervention such as dry fasts, water fasts, or ketogenic diets.
Anyone who has experienced significant weight loss in the past three months prior to study participation.
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants will receive two investigational herbal supplements daily for 24 weeks.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Citruslabs

Las Vegas, United StatesOpen Citruslabs in Google Maps
Recruiting
One Study Center